The assessment of physiologic reserve prior to surgery is a critical aspect of perioperative risk stratification, particularly in the aging and comorbid population. Physiologic reserve, which refers to the functional capacity of organ systems to withstand stress, is a dynamic and multifactorial determinant of postoperative outcomes. This review synthesizes current evidence on methods and clinical relevance of physiologic reserve evaluation, highlights the epidemiological burden of impaired reserve, discusses underlying mechanisms, and presents a guideline-oriented approach for clinicians. Emphasis is placed on practical implementation, interpretation of assessment tools, and recent advances that may improve perioperative care and surgical outcomes.
Preoperative evaluation of surgical patients has evolved beyond the assessment of comorbidities and chronological age to incorporate the concept of physiologic reserve the ability of an individual to compensate for surgical stress. Given the increasing complexity of surgical candidates, particularly older adults and those with multiple chronic conditions, determining physiologic reserve is integral to anticipating complications, guiding perioperative management, and informing shared decision-making. This review aims to provide a comprehensive, evidence-based overview of physiologic reserve evaluation, its clinical implications, and contemporary strategies for its application in surgical care.
The prevalence of impaired physiologic reserve is rising in parallel with the aging population and the growing burden of chronic disease. Epidemiological studies estimate that up to 50% of patients over 65 years presenting for major non-cardiac surgery have some degree of frailty or diminished reserve. These patients experience a two- to three-fold higher risk of postoperative complications, prolonged hospitalization, institutionalization, and mortality. The societal and healthcare burdens are significant, with increased resource utilization and adverse outcomes driving efforts to refine preoperative risk assessment and optimize surgical candidacy.
Physiologic reserve encompasses the integrated capacity of multiple organ systems including cardiovascular, pulmonary, renal, hepatic, musculoskeletal, and neurocognitive to respond to physiologic stress. Age-related sarcopenia, reduced cardiac output, impaired pulmonary function, and decreased renal clearance contribute to diminished reserve. Additionally, subclinical inflammation, mitochondrial dysfunction, and hormonal dysregulation may further compromise adaptive responses. The pathophysiology of impaired reserve is multifactorial, involving both intrinsic (genetic, biological) and extrinsic (lifestyle, environmental) factors, ultimately resulting in reduced homeostatic capacity during surgical insult.
Several risk factors predispose individuals to reduced physiologic reserve. Advanced age is the most prominent, but comorbidities such as heart failure, chronic obstructive pulmonary disease, diabetes mellitus, chronic kidney disease, and malignancy are significant contributors. Polypharmacy, nutritional deficiencies, cognitive impairment, and physical inactivity exacerbate vulnerability. Socioeconomic deprivation and limited access to healthcare may also play a role, making comprehensive preoperative evaluation essential in identifying at-risk patients.
Clinical manifestations of impaired physiologic reserve are often subtle and may not be apparent until the patient is subjected to stress. Key features include decreased exercise tolerance, unexplained fatigue, weight loss, recurrent falls, and slowed gait speed. In the perioperative setting, patients with low reserve are more likely to develop postoperative delirium, infection, delayed wound healing, and organ dysfunction. Frailty syndromes, characterized by weakness, exhaustion, and low physical activity, are closely associated with diminished reserve and adverse outcomes.
The diagnosis of impaired physiologic reserve relies on a combination of clinical assessment and objective testing. Standardized tools include the Clinical Frailty Scale, Fried Frailty Criteria, and gait speed measurement. Cardiopulmonary exercise testing (CPET) provides quantitative evaluation of aerobic capacity and ventilatory efficiency, while biomarkers such as B-type natriuretic peptide (BNP) and C-reactive protein (CRP) may offer additional prognostic information. Integrating these tools into preoperative workflows enables more accurate risk stratification and tailored perioperative management.
Optimizing physiologic reserve prior to surgery involves addressing modifiable risk factors through multidisciplinary interventions. Prehabilitation structured exercise programs combined with nutritional support and psychological counseling has demonstrated efficacy in improving functional status and reducing postoperative complications. Medical optimization of comorbidities, medication review, and correction of nutritional deficits are essential components. For high-risk patients, shared decision-making regarding surgical candidacy and goals of care should be prioritized, potentially considering non-operative management when appropriate.
Recent advances in the evaluation of physiologic reserve include the development of novel biomarkers and digital health technologies. Wearable devices capable of monitoring physical activity, heart rate variability, and sleep patterns provide continuous, objective data that may enhance risk prediction. Machine learning algorithms incorporating electronic health record data, laboratory values, and physiologic parameters are being explored to refine individualized risk assessment. Additionally, ongoing trials are investigating pharmacologic and regenerative therapies aimed at augmenting reserve in vulnerable populations.
Contemporary guidelines from professional societies such as the American College of Surgeons and the American Geriatrics Society recommend routine assessment of frailty and physiologic reserve in older surgical candidates. Multidimensional tools are endorsed over single-parameter assessments, and integration of reserve evaluation into shared decision-making is emphasized. Guidelines advocate for prehabilitation, optimization of comorbidities, and multidisciplinary perioperative care as standard practices for at-risk populations.
The evaluation of physiologic reserve prior to surgery is an essential component of modern perioperative medicine, providing critical insight into patient vulnerability, informing risk stratification, and guiding tailored management strategies. As surgical populations become increasingly complex, embracing comprehensive, evidence-based approaches to reserve assessment will be paramount in improving outcomes and advancing patient-centered care. Future research into novel assessment modalities and interventions holds promise for further enhancing perioperative safety and success.
1.
Year in Review: Non-Small Cell Lung Cancer
2.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
5.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
1.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
2.
The Danger of Methemoglobinemia and How to Prevent It
3.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Thromboprophylaxis In Medical Settings
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation